Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.
Year: 2014
Type: article
Study design: Observational Study
Source: PubMed
Institutions: Tokushima University, Tokushima University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1863162242
